Patients with cancer experience a higher burden of SARS-CoV-2 infection, disease severity,
complications, and mortality, than the general population. SARS-CoV-2 mRNA vaccines are …

Importance Patients with cancer undergoing treatment are at high risk of COVID-19 following
SARS-CoV-2 infection; however, their ability to produce an adequate antibody response to …

Patients with cancer are considered to be at high-risk for SARS-CoV-2 infection and severe
COVID-19 (Bakouny et al., 2020). Our ''SOAP-02''(Sars-CoV-2 fOr cAncer Patients) study has …

Patients with cancer, particularly those under active therapy, are at increased risk of
morbidity and mortality when infected with SARS-CoV-2 (Bakouny et al., 2020; Grivas et al …

PURPOSE The immunogenicity and reactogenicity of SARS-CoV-2 vaccines in patients with
cancer are poorly understood. METHODS We performed a prospective cohort study of adults …

Purpose Patients with cancer have an increased risk of coronavirus disease 2019 (COVID-
19) and an attenuated responses to various vaccines. This meta-analysis aims to assess the …

Purpose Initial findings in patients with cancer suggest a lower seroconversion to SARS-
CoV-2 vaccination possibly related to myelo-immunosuppressive therapies. We conducted a …

Background: Cancer patients show increased morbidity with COVID-19 and need effective
immunization strategies. Many healthcare regulatory agencies recommend administering …

Background Efficacy and safety data of COVID-19 vaccines among cancer populations have
been limited; however, preliminary data from recent studies have emerged regarding their …

Importance The efficacy and safety profile of SARS-CoV-2 vaccines have been acquired
from phase 3 studies; however, patients with cancer were not represented in these trials …